The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Dolby Laboratories's revenues will wane -5.1% and EPS will contract -27.6%.
The average estimate for revenue is $221.6 million. On the bottom line, the average EPS estimate is $0.55.
Last quarter, Dolby Laboratories notched revenue of $224.8 million. GAAP reported sales were 7.8% lower than the prior-year quarter's $243.8 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.61. GAAP EPS of $0.49 for Q4 were 32% lower than the prior-year quarter's $0.72 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 88.0%, 150 basis points worse than the prior-year quarter. Operating margin was 32.0%, 1,510 basis points worse than the prior-year quarter. Net margin was 22.9%, 950 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $918.4 million. The average EPS estimate is $2.29.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 3,930 members out of 4,032 rating the stock outperform, and 102 members rating it underperform. Among 1,125 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 1,104 give Dolby Laboratories a green thumbs-up, and 21 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Dolby Laboratories is hold, with an average price target of $37.50.
Looking for alternatives to Dolby Laboratories? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.
- Add Dolby Laboratories to My Watchlist.